Tag: leukemia
May 5, 2020
AbbVie’s VENCLEXTA Gets Health Canada Approval to Treat CLL
Health Canada has approved AbbVie's VENCLEXTA in combination with obinutuzumab to treat adult patients with previously untreated CLL.
September 27, 2018
Biocure CEO: Our CAR-T Biosimilar Technology is Helping Terminal Leukemia Patients Recover
Biocure Technology CEO Dr. Sang Mok Lee believes the products Biocure is developing for the healthcare industry further the company’s... July 20, 2018
FDA Grants Approval of Agios’ Pharmaceuticals’ TIBSOVO®
Agios Pharmaceuticals (NASDAQ:AGIO) has announced that TIBSOVO was granted approval from the US Food and Drug Administration (FDA) for treatment...
July 15, 2018
5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top
Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...
July 3, 2018
4 Top Biotech Stocks on the TSX of Q2 2018
Which biotech stocks on the TSX have performed the best year-to-date? These four companies have risen to the top of...
May 10, 2018
3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma
3D Signatures Inc. (TSXV:DXD,OTCQB:TDSGF), a personalized medicine company with a proprietary software platform (TeloViewTM) based on the three-dimensional analysis of... May 8, 2018
